Admission International Normalized Ratio Levels, Early Treatment Strategies, and Major Bleeding Risk Among Non–ST-Segment–Elevation Myocardial Infarction Patients on Home Warfarin Therapy
Sumeet Subherwal(Washington University in St. Louis), Tracy Y. Wang(Clinical Research Institute), Renato D. Lópes(Duke University), Brian F. Gage(Washington University in St. Louis), Eric D. Peterson(The University of Texas Southwestern Medical Center), Anita Y. Chen(University of Rochester Medicine), Deepak L. Bhatt(Mount Sinai Hospital), Richard G. Bach(Washington University in St. Louis), Stephen D. Wiviott(Brigham and Women's Hospital), Matthew T. Roe(Inserm), Jeffrey B. Washam(Jeffrey Modell Foundation), Karen P. Alexander(Clinical Research Institute)
Cited by 18
Related Papers
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
|New England Journal of Medicine|2007|6.7k
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2018|6.3k
Edoxaban versus Warfarin in Patients with Atrial Fibrillation
|New England Journal of Medicine|2013|5.2k
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
|New England Journal of Medicine|2018|3.5k
An Updated Definition of Stroke for the 21st Century
|Stroke|2013|3.5k